TD Cowen Maintains Buy on CME Group, Raises Price Target to $300
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice TargetHot
TD Cowen analyst Bill Katz maintains CME Group (NASDAQ:CME) with a Buy and raises the price target from $292 to $300.
TD Cowen analyst Bill Katz maintains CME Group (NASDAQ:CME) with a Buy and raises the price target from $292 to $300.